Amanda Kelsey
Family · Warren, MINPI 1548615172
Payments from drug & device makers
Across 201 payments — averaging $16.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Collegium Pharmaceutical, Inc.$394
- AbbVie$375
- Lilly USA, LLC$224
- Abbott$174
- Boehringer Ingelheim$170
- GSK$162
- plus $2K from 32 others
What the payments were for
- Food & beverage$3,377100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 21 | $394 |
| AbbVie | 20 | $375 |
| Lilly USA, LLC | 15 | $224 |
| Abbott | 18 | $174 |
| Boehringer Ingelheim | 8 | $170 |
| GSK | 8 | $162 |
| Pfizer | 9 | $150 |
| Amarin Pharma, Inc. | 13 | $141 |
| Novo Nordisk | 12 | $132 |
| Amgen(2 entities) | 7 | $112 |
| Johnson & Johnson | 7 | $102 |
| Scilex Pharmaceuticals Inc. | 5 | $90 |
| Sanofi-aventis U.S. LLC | 6 | $88 |
| Esperion Therapeutics, Inc. | 6 | $85 |
| Myovant Sciences Inc. | 1 | $81 |
| SK Life Science, Inc. | 1 | $80 |
| Globus Medical | 2 | $73 |
| Novartis | 4 | $69 |
| Bayer | 5 | $69 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $69 |
| Biohaven Pharmaceuticals, Inc. | 4 | $68 |
| Dexcom, Inc. | 3 | $50 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $47 |
| AstraZeneca | 3 | $40 |
| Saluda Medical Americas, Inc. | 1 | $38 |
| Tersera Therapeutics LLC | 1 | $37 |
| Kowa Pharmaceuticals America, Inc. | 3 | $36 |
| Xeris Pharmaceuticals, Inc. | 2 | $29 |
| Sobi, Inc | 1 | $25 |
| Genmab U.S., Inc. | 1 | $25 |
| Fennec Pharmaceuticals, Inc. | 1 | $24 |
| Recordati_rare_diseases_inc. | 1 | $24 |
| ADC Therapeutics America, Inc. | 1 | $22 |
| Arbor Pharmaceuticals, Inc. | 1 | $20 |
| Nabriva Therapeutics, PLC | 1 | $17 |
| Astellas Pharma US Inc | 1 | $16 |
| Alfasigma USA, Inc. | 1 | $11 |
| Genentech USA, Inc. | 1 | $9 |
How this compares
$3,377 in reported general payments places this provider in the 90th percentile of 3,657 family providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 44 | $10,781 |
| OxycontinOxycodone Hcl | 12 | $9,047 |
| Gabapentin | 247 | $3,292 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 163 | $2,840 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 120 | $2,312 |
| Lidocaine | 19 | $1,572 |
| Morphine Sulfate ErMorphine Sulfate | 45 | $1,270 |
| Oxycodone Hcl | 49 | $754 |
| Pregabalin | 34 | $715 |
| Baclofen | 12 | $686 |
| Tizanidine Hcl | 24 | $320 |
| Methadone Hcl | 20 | $274 |
| Methylprednisolone | 50 | $266 |
| Tramadol Hcl | 49 | $126 |
| Cyclobenzaprine Hcl | 14 | $86 |
Paid to pharmacies, not to this prescriber.
Other family in Warren
- Karen Teves-FrazierWarren$20K
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- David KocendaLapeer$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.